Intel’s Mobileye valued at $21.8 bn in IPO

Shares of Mobileye Global are up 30 percent in early afternoon trading on Wednesday following its U.S. debut, valuing the self-driving technology unit of Intel at $21.8 billion as investors lapped up what could be the last major IPO of 2022.
Mobileye IPO
The debut comes after a turbulent period when Mobileye settled for a third of the $50 billion valuation it was targeting earlier in its IPO.

“The valuation probably wasn’t what we wanted it to be. But there was a lot of value in gaining that public company platform now,” said Dan Galves, chief communications officer at Mobileye.

Galves added it is important for Mobileye to generate product visibility now as that filters back to customers. He pointed to the SuperVision product, launched with Zeeker last year, as a reason why it was the right time to go public.

Before being acquired by chipmaker Intel in a $15.3 billion deal in 2017, Mobileye had been listed on the New York Stock Exchange since 2014.

Mobileye develops autonomous driving technologies and competes with Alphabet Inc’s Waymo, General Motors Co’s Cruise and other automakers who have moved to design in-house driving assistance technology.

Competition is getting fierce in the assisted driving market as Nvidia and Qualcomm both vie for automaker customers.

Mobileye’s Galves said based on its design wins with automakers, its assisted driving systems would be deployed in 270 million cars by 2030, although he did not give a dollar amount for that. He said even if Mobileye stopped winning new business today, that future volume projection would still hold, adding that the current business brings in an average $45-50 per car.

He added that there is an opportunity to increase the amount of revenue generated per vehicle going forward with increased technology. The self-driving company does not have a timing for significant amount of AVs on the road, he said.

Qualcomm said in September that its automotive business pipeline increased to $30 billion and Nvidia in March put its number at $11 billion. That number has been jumping strongly for both companies.